Concepedia

Karen A. Joiner

KA

Statistics

Publications

2

Citations

208

H-Index

2

Active since

1990

Affiliations

New Frontier(Current)

Karen A. Joiner is an author at New Frontier specializing in neuropharmacology, 5-hydroxytryptamine 3 receptor antagonists, and 5-hydroxytryptamine receptor pharmacology.

Publications per year

1990–1990

2

Publications

2

5-Hydroxytryptamine (5-HT3) receptor antagonists. 1. Indazole and indolizine-3-carboxylic acid derivatives

José Luis Bermúdez, Charles S. Fake, Graham F. Joiner et al. · Journal of Medicinal Chemistry · 1990 · 153 citations · Full text

, , +14

5-Hydroxytryptamine (5-HT3) receptor antagonists. 2. 1-Indolinecarboxamides

José Luis Bermúdez, Steven Dabbs, Karen A. Joiner et al. · Journal of Medicinal Chemistry · 1990 · 55 citations

, , +13

1–2 of 2